Patent · US Active

Lipase inhibiting composition

US8343543B2 · kind B2 · utility

0Cited by

9References

19Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Karsten Maeder · Glückstadt, DE
Rainer E. Martin · Basel, CH
Susanne Raab · Echterdingen, DE
Lukas Scheibler · Laguna Beach, US
Thomas Schindler · Soest, DE
Marco Schroeder · Heidelberg, DE

Key dates

Filing date	Aug 19, 2011
Grant date	Jan 1, 2013
Priority date	—
Expiry date	Aug 19, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical compositions that contain a lipase inhibitor having a melting point ≧37° C., a sucrose fatty acid ester wherein the sucrose fatty acid ester is a mono-, di-, tri- or tetra-ester, and optionally one or more pharmaceutically acceptable excipients, are useful for treatment of obesity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.